During the past decade, A&R Research Group, LLC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "A&R Research Group, LLC" are "Dyslipidemias" (2 trials), "Hyperlipidemia" (2 trials), "Cardiovascular Disease" (1 trials), "High Cholesterol" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "A&R Research Group, LLC" in a lesser frequency.

Most popular intervention types in "A&R Research Group, LLC" are "Drug" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ARO-APOC3" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Bococizumab 150mg" (1 trials) and "Bococizumab 150mg placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "A&R Research Group, LLC" are 6 trials for "All" genders.

Currently, there are NaN active trials in "A&R Research Group, LLC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in A&R Research Group, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in A&R Research Group, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".